Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
821studies shown
RecruitingNCT05934474

Biocollection on Peripheral Inflammation

This recruiting study focuses on bipolarity and currently lists sites or participation links in France.

BipolarityBiologicalOver 18 Years
Countries
France
Sponsor
Nantes University Hospital
Condition
Bipolarity
RecruitingNCT06758414

CBT-CP for Veterans With SMI

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
RecruitingNCT04580134

CLOZAPINE Response in Biotype-1

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
RecruitingNCT06107764

Cerebellar Modulation of Cognition in Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDeviceFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia
RecruitingNCT03217110

Cerebellar Stimulation and Cognitive Control

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDeviceFrom 18 Years to 90 Years
Countries
United States
Sponsor
Krystal Parker, PhD
Condition
Schizophrenia
Not Yet RecruitingNCT07263022

Cognitive Strategies in Early Psychosis 2

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
Global
Sponsor
University of Minnesota
Condition
Schizophrenia
RecruitingNCT05945277

Critical Time Intervention-Peer Support

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Portugal.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Portugal
Sponsor
Lisbon Institute of Global Mental Health - LIGMH
Condition
Schizophrenia
Active Not RecruitingNCT05877716

EPI-MINN: Targeting Cognition and Motivation - National

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Not Yet RecruitingNCT06695676

Effects of Lurasidone on Left Ventricle Systolic Functions

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaDiagnostic TestFrom 18 Years to 65 Years
Countries
Turkey (Türkiye)
Sponsor
Aydin Adnan Menderes University
Condition
Schizophrenia
Not Yet RecruitingNCT06898879

Enhancing Veteran-Clinical Collaboration in VA PRRCs

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
RecruitingNCT06313918

Exercise Therapy in Mental Disorders-study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Norway.

SchizophreniaOtherOver 16 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
Schizophrenia
RecruitingNCT06740890

Exercise and Olanzapine-samidorphan

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Enrolling By InvitationNCT04987229

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

This enrolling by invitation study focuses on schizophrenia and currently lists sites or participation links in Argentina, Brazil, Colombia, Mexico, United States.

SchizophreniaDrugFrom 10 Years to 17 Years
Countries
Argentina, Brazil, Colombia, Mexico, United States
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Enrolling By InvitationNCT06880796

Mindfulness-Based Therapy for Serious Mental Illness

This enrolling by invitation study focuses on depression and currently lists sites or participation links in United States.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Depression
Not Yet RecruitingNCT06115200

Norwegian Adult Mental Health Registry

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherOver 18 Years
Countries
Global
Sponsor
Helse Stavanger HF
Condition
Schizophrenia
RecruitingNCT07085923

Norwegian Mental Illness Heart Health Study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Norway.

SchizophreniaBehavioralFrom 25 Years to 70 Years
Countries
Norway
Sponsor
Madeleine Elisabeth Angelsen
Condition
Schizophrenia
Not Yet RecruitingNCT05457127

Obstructive Sleep Apnea Treatment in Serious Mental Illness

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDeviceFrom 40 Years to 70 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Enrolling By InvitationNCT06558201

Open Label Extension Study of NCT06221852

This enrolling by invitation study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia
Enrolling By InvitationNCT00762866

Psychiatric Genotype/Phenotype Project Repository

This enrolling by invitation study focuses on depression and currently lists sites or participation links in United States.

DepressionOtherFrom 16 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University
Condition
Depression
RecruitingNCT07082777

Recovery in Telling Life Stories

This recruiting study focuses on depression and currently lists sites or participation links in Denmark.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
University of Aarhus
Condition
Depression
RecruitingNCT01980147

Skills for Wellness

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaBehavioralFrom 9 Years to 21 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT06700902

Taking Action for College Students

This recruiting study focuses on depression and currently lists sites or participation links in United States.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Temple University
Condition
Depression
RecruitingNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolarity

This recruiting study focuses on schizophrenia and currently lists sites or participation links in France.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Schizophrenia
RecruitingNCT04610697

Cognitive Remediation in Forensic Mental Health Care

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
Canada
Sponsor
The Royal Ottawa Mental Health Centre
Condition
Schizophrenia
RecruitingNCT06045897

EEG Microstates Across At-Risk Mental States

This recruiting study focuses on depression and currently lists sites or participation links in France.

DepressionBiologicalFrom 15 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression
RecruitingNCT06384209

The Friendship Bench Plus Trial

This recruiting study focuses on depression and currently lists sites or participation links in Zimbabwe.

DepressionDrugOver 18 Years
Countries
Zimbabwe
Sponsor
University of Bern
Condition
Depression
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Australia.

SchizophreniaOtherFrom 12 Years to 30 Years
Countries
Australia
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
RecruitingNCT06562608

Anticholinergic Deprescription in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDrugFrom 40 Years to 70 Years
Countries
United States
Sponsor
Deepak K. Sarpal, M.D.
Condition
Schizophrenia
RecruitingNCT06257056

Deep Brain Stimulation for Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Bradley Lega
Condition
Schizophrenia
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity Type I

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Australia.

SchizophreniaDeviceFrom 18 Years to 50 Years
Countries
Australia
Sponsor
diaMentis Inc.
Condition
Schizophrenia
RecruitingNCT05805397

Effectiveness of Motivation Skills Training (MST)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
RecruitingNCT06301347

Learning Through Play Plus for Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Pakistan.

SchizophreniaBehavioralOver 18 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
Active Not RecruitingNCT06442462

Study of SPG302 in Adults With Schizophrenia

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Australia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Spinogenix
Condition
Schizophrenia
Not Yet RecruitingNCT07184710

This Hospital-based Observational Study Employed a Study Will be Conducted in Sohag University Hospital Clinics Aiming to Ensure Cases Presented With Psychosis in Two Phases to Differentiate Into Two Groups a Case of Schizophrenia or a Case of Methamphetamine Induced Psychosis.

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
Sohag University
Condition
Schizophrenia
RecruitingNCT06911931

Visual Perception in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Rochester
Condition
Schizophrenia
Not Yet RecruitingNCT06364241

Focus Groups on Cognitive Function in Psychosis

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
King's College London
Condition
Schizophrenia
RecruitingNCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States.

SchizophreniaOtherFrom 5 Years to 17 Years
Countries
Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05142735

Effects of NAC on Symptoms of CHR Patients

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Argentina, Brazil, China, India, Japan, Taiwan, United States.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Argentina, Brazil, China, India, Japan, Taiwan, United States
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
RecruitingNCT04745143

Monotherapy of an NMDA Enhancer for Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Taiwan.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
RecruitingNCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, Puerto Rico, Romania, Serbia, Slovakia, South Korea, Spain, Turkey (Türkiye), Ukraine, United States.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, Puerto Rico, Romania, Serbia, Slovakia, South Korea, Spain, Turkey (Türkiye), Ukraine, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT06774417

Digital Strategies to Advance Help-Seeking - Aim 3

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 12 Years to 29 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
RecruitingNCT05770375

Tolerability of MDMA in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Anya Bershad, MD, PhD
Condition
Schizophrenia
Not Yet RecruitingNCT07470437

The Mouth Matters in Mental Health Trial -2

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
Lancashire and South Cumbria NHS Foundation Trust
Condition
Schizophrenia
RecruitingNCT05304767

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Bulgaria, Czechia, India, Japan, Poland, Romania, Serbia, United Kingdom, United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Bulgaria, Czechia, India, Japan, Poland, Romania, Serbia, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT07460453

Racial Disparities in the Expression of Paranoia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
RecruitingNCT06944847

Vaping and Smoking Project in People With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 21 Years to 50 Years
Countries
United States
Sponsor
State University of New York at Buffalo
Condition
Schizophrenia
RecruitingNCT05527210

Prebiotic Treatment in People With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT07450027

LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaOtherFrom 18 Years to 49 Years
Countries
Turkey (Türkiye)
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Not Yet RecruitingNCT07447960

LRFN5 and OLFM4 in Schizoaffective Disorder

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey (Türkiye)
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
RecruitingNCT07084831

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria, Belgium, Czechia, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Spain.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Austria, Belgium, Czechia, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Spain
Sponsor
European Group for Research In Schizophrenia
Condition
Schizophrenia
Not Yet RecruitingNCT07434973

Stratification and Treatment in Early Psychosis Study - PROMOTE

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria, Canada, Finland, Germany, Greece, Italy, Netherlands, Spain, Switzerland, United Kingdom.

SchizophreniaOtherFrom 12 Years to 35 Years
Countries
Austria, Canada, Finland, Germany, Greece, Italy, Netherlands, Spain, Switzerland, United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingNCT06641297

White Matter Plasticity in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 15 Years to 45 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT07419321

Social Isolation and Aging in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands, Spain, United Kingdom, United States.

SchizophreniaOtherFrom 40 Years to 70 Years
Countries
Netherlands, Spain, United Kingdom, United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
RecruitingNCT07231497

Cognitive Strategies in Early Psychosis 1

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Active Not RecruitingNCT05558332

Youth Nominated Support Team

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Irvine
Condition
Schizophrenia
RecruitingNCT06155682

TMS for Inhibition Enhancement in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Active Not RecruitingNCT05857137

Psychosis TMS Study

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Not Yet RecruitingNCT07393464

PQQ for Cognitive and Negative Symptoms

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Global
Sponsor
Tianjin Anding Hospital
Condition
Schizophrenia
RecruitingNCT07397975

Speech-based Assessment of Relapse Risk in People With Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Czechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye).

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Czechia, Ireland, Netherlands, Norway, Switzerland, Turkey (Türkiye)
Sponsor
Philipp Homan
Condition
Schizophrenia
RecruitingNCT05185128

Neural Basis of Social Cognition Deficits

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 12 Years to 18 Years
Countries
United States
Sponsor
Loma Linda University
Condition
Schizophrenia
Active Not RecruitingNCT02926859

Enhancing Recovery in Early Schizophrenia

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Germany.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia
RecruitingNCT06672588

Magnetic Seizure Therapy for Schizophrenia - Trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT07383324

Heat Stress in Individuals With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Schizophrenia
RecruitingNCT07177261

Inter-Brain Synchrony in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingNCT07378150

Clay Therapy in Schizophrenia Patients

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaOtherOver 18 Years
Countries
Turkey (Türkiye)
Sponsor
Kutahya Health Sciences University
Condition
Schizophrenia
Enrolling By InvitationNCT01088386

Zyprexa® Relprevv™ Patient Care Program

This enrolling by invitation study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
RecruitingNCT03995121

SV2 PET Imaging With [11C]APP311

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 85 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Not Yet RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
LB Pharmaceuticals Inc.
Condition
Schizophrenia
Not Yet RecruitingNCT07342465

Gamma Light and Sound Stimulation in Schizophrenia

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts Institute of Technology
Condition
Schizophrenia
Not Yet RecruitingNCT06142422

Intermittent Theta Burst Stimulation of the Precuneus

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in France.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
France
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Condition
Schizophrenia
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Not Yet RecruitingNCT07326124

Stratification and Treatment in Early Psychosis Study -ASSIST

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom.

SchizophreniaOtherFrom 16 Years to 50 Years
Countries
Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingNCT06502964

Study of ALTO-101 in Patients With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 21 Years to 55 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Schizophrenia
Not Yet RecruitingNCT06909422

Mobile Thinking Intervention: A Inital Test

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Alabama at Birmingham
Condition
Schizophrenia
Not Yet RecruitingNCT07157293

Online Intervention To Improve Motivation

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Alabama at Birmingham
Condition
Schizophrenia
Active Not RecruitingNCT07292233

A Food Effect Study of LY03020 in Healthy Subjects

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in China.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Not Yet RecruitingNCT06778564

Stratification and Treatment in Early Psychosis Study - ENHANCE

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria, Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom.

SchizophreniaOtherFrom 16 Years to 40 Years
Countries
Austria, Germany, Greece, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingNCT07003529

Role of Inferior Colliculi in Auditory Hallucinations

This recruiting study focuses on schizophrenia and currently lists sites or participation links in France.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia
RecruitingNCT06642675

nTMS for Negative Symptom in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in China.

SchizophreniaOtherUp to 60 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Active Not RecruitingNCT06539780

Imagery Rescripting as a Treatment for Early Psychosis

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherFrom 16 Years to 45 Years
Countries
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition
Schizophrenia
Not Yet RecruitingNCT07252752

Dopamine and Insulin in Psychosis

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Schizophrenia
Active Not RecruitingNCT05112432

EPI-MINN: Targeting Cognition and Motivation

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
RecruitingNCT06581302

Magnetic Seizure Therapy for Psychotic Disorders

This recruiting study focuses on schizophrenia and currently lists sites or participation links in China.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Shanghai Jiao Tong University School of Medicine
Condition
Schizophrenia
Not Yet RecruitingNCT07196423

Early Psychosis: Investigating Cognition

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
Schizophrenia
RecruitingNCT07234708

Feeling Safe Study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Spain.

SchizophreniaOtherOver 18 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
Active Not RecruitingNCT05968638

Ketogenic Diet in People With Schizophrenia

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT07119268

SPARK Healthy Sleep

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
RecruitingNCT05945602

Neurophysiologic Biomarkers for Cognitive Rehabilitation

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
RecruitingNCT03817502

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Bulgaria, Colombia, Mexico, Romania, Russia, Serbia, Ukraine, United States.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
Bulgaria, Colombia, Mexico, Romania, Russia, Serbia, Ukraine, United States
Sponsor
Gedeon Richter Plc.
Condition
Schizophrenia
RecruitingNCT06336382

Tau Biomarkers in Late-onset Psychosis (LOP)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 65 Years to 85 Years
Countries
United States
Sponsor
Jeremy Koppel
Condition
Schizophrenia
RecruitingNCT05958875

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria, Germany, Italy, Spain, United Kingdom.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Austria, Germany, Italy, Spain, United Kingdom
Sponsor
Dr. Inge Winter
Condition
Schizophrenia
Enrolling By InvitationNCT07155096

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

This enrolling by invitation study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
RecruitingNCT05590637

Comparing Antipsychotic Medications in LBD Over Time

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOther
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Schizophrenia
RecruitingNCT06236048

Energetics and Glutamate in Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Not Yet RecruitingNCT07122531

Recovery With Exogenous Ketones and Antipsychotics

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Canada.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Université de Sherbrooke
Condition
Schizophrenia
Not Yet RecruitingNCT07108673

Value of Voxel-Based Morphometry in Schizophrenia

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Global.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Global
Sponsor
Assiut University
Condition
Schizophrenia
Not Yet RecruitingNCT06817980

Disorders of the Sense of Self and Physical Activity

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in France.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
RecruitingNCT05929352

Song-making In a Group (SING)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Not Yet RecruitingNCT07086040

Effects of RAS in SZ

This not yet recruiting study focuses on schizophrenia and currently lists sites or participation links in Taiwan.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Taiwan
Sponsor
Shu-Mei Wang
Condition
Schizophrenia
Active Not RecruitingNCT07080827

TTM-Based Social Media Psychoeducation for Psychosis

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey (Türkiye)
Sponsor
Istanbul University - Cerrahpasa
Condition
Schizophrenia
Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Active Not RecruitingNCT06126224

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Belgium, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Turkey (Türkiye), United States.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Belgium, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Turkey (Türkiye), United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, Puerto Rico, Romania, Serbia, Slovakia, South Korea, Spain, Turkey (Türkiye), United Kingdom, United States.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, Puerto Rico, Romania, Serbia, Slovakia, South Korea, Spain, Turkey (Türkiye), United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT05511363

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Bulgaria, Croatia, Czechia, France, Germany, Italy, Serbia, Slovakia, Spain, United Kingdom, United States.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Bulgaria, Croatia, Czechia, France, Germany, Italy, Serbia, Slovakia, Spain, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Brazil, Bulgaria, Chile, Czechia, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States.

SchizophreniaOtherFrom 55 Years to 95 Years
Countries
Brazil, Bulgaria, Chile, Czechia, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Active Not RecruitingNCT05310838

Optimizing Engagement in Services for First-Episode Psychosis

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherFrom 15 Years to 35 Years
Countries
United States
Sponsor
California State University, San Bernardino
Condition
Schizophrenia
RecruitingNCT07459244

ECG Findings in Methamphetamine Use

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Turkey (Türkiye).

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey (Türkiye)
Sponsor
Elazığ Mental Health and Diseases Hospital
Condition
Schizophrenia
Enrolling By InvitationNCT06194799

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

This enrolling by invitation study focuses on schizophrenia and currently lists sites or participation links in Brazil, Bulgaria, Chile, Czechia, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States.

SchizophreniaOtherFrom 55 Years to 95 Years
Countries
Brazil, Bulgaria, Chile, Czechia, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Active Not RecruitingNCT05967195

Trial to Increase FEP Attendance

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in United States.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Schizophrenia
RecruitingNCT06540833

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Bulgaria, Croatia, Czechia, Poland, Romania, Serbia, Slovakia, Spain, United States.

SchizophreniaOtherOver 55 Years
Countries
Bulgaria, Croatia, Czechia, Poland, Romania, Serbia, Slovakia, Spain, United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
RecruitingNCT06582901

Interventions for Clinical High Risk Youth in Tunisia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Tunisia.

SchizophreniaOtherFrom 14 Years to 28 Years
Countries
Tunisia
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
RecruitingISRCTN79796233

A clinical trial to investigate how effective a stimulant medication is compared to a non-stimulant medication in patients who have been diagnosed with attention deficit hyperactivity disorder (ADHD) and also have a history of either psychosis or Bipolarity

This recruiting study focuses on adhd and currently lists sites or participation links in United Kingdom, England.

ADHDOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
University of Birmingham
Condition
ADHD
RecruitingISRCTN44497123

Effects of personalized exercise training on physical activity, health-related fitness, sleep quality, and quality of life among middle-aged and older adults with multiple health problems

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Taiwan.

SchizophreniaOther
Countries
Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Taiwan
Sponsor
National Defense Medical Center
Condition
Schizophrenia
RecruitingISRCTN36607067

Pharmacological treatment of psychotic depression

This recruiting study focuses on depression and currently lists sites or participation links in Netherlands.

DepressionOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Utrecht (UMCU) (The Netherlands)
Condition
Depression
RecruitingISRCTN83479057

A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, Australia, Austria, Germany, Israel, Italy, Spain.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
United Kingdom, Australia, Austria, Germany, Israel, Italy, Spain
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
RecruitingISRCTN12748453

Guided self-help CBT for voices

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Sussex Partnership NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN11998005

Light-dark and activity rhythm therapy for sleep: a study to explore the practicality of delivering the therapy, and participant's experiences and views of whether the intervention is acceptable, in people with schizophrenia spectrum disorders

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
University of Manchester
Condition
Schizophrenia
RecruitingISRCTN55682735

Optimising AVATAR therapy for distressing voices

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Scotland.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
United Kingdom, England, Scotland
Sponsor
King's College London
Condition
Schizophrenia
RecruitingISRCTN16166070

Increasing access to CBT for psychosis patients

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Sussex Partnership NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN45308981

Talking With Voices

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Greater Manchester Mental Health NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN60175188

The cognition game study

This recruiting study focuses on depression and currently lists sites or participation links in Netherlands.

DepressionOther
Countries
Netherlands
Sponsor
MyCognition
Condition
Depression
RecruitingISRCTN17852603

Mindfulness for paranoia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Surrey and Borders Partnership NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN12360747

Community mental health nursing

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Indonesia.

SchizophreniaOther
Countries
Indonesia
Sponsor
DRPM University of Indonesia
Condition
Schizophrenia
RecruitingISRCTN18705064

Psychological support for fears about other people

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingISRCTN74048461

Positive Emotions Program for Schizophrenia (PEPS)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Switzerland.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
La Source School of Nursing Sciences (HEdS La Source)
Condition
Schizophrenia
RecruitingISRCTN11422802

Worry & persecutory delusions: a brief group intervention

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom, England
Sponsor
Oxleas NHS foundation Trust
Condition
Schizophrenia
RecruitingISRCTN88145142

Feasibility trial of ClinTouch-CareLoop Enhanced Management

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom, England
Sponsor
Manchester Mental Health and Social Care Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN06815355

Investigating Attention Control Training in psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
Greater Manchester West NHS Foundation Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN19447796

Structured lifestyle education for people wIth schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Sheffield Health and Social Care NHS Foundation Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN23930628

Neurofeedback treatment of auditory verbal hallucinations

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Switzerland.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Switzerland
Sponsor
University Hospital of Psychiatry Bern (Switzerland)
Condition
Schizophrenia
RecruitingISRCTN09150095

Benefits of Exercise in Early Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom, England
Sponsor
University of Manchester (UK)
Condition
Schizophrenia
RecruitingISRCTN84658943

To tweet or not to tweet about schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
Nottinghamshire Healthcare NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN16659871

Metacognitive Reflection & Insight Therapy (MERIT)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Netherlands
Sponsor
University of Groningen (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN76324634

Adherence therapy for schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Switzerland.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England, Switzerland
Sponsor
Clinic of Psychiatry and Psychotherapy Bethel (Germany)
Condition
Schizophrenia
RecruitingISRCTN71943786

ENhancing DElivery And outcomes of VOcational Rehabilitation

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom, England
Sponsor
Kings College London (KCL) (UK)
Condition
Schizophrenia
RecruitingISRCTN59501939

Cognitive mechanisms of change in delusions

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Kings College London (KCL) (UK)
Condition
Schizophrenia
RecruitingISRCTN25898179

Rehabilitation Effectiveness for Activities for Life

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
University College London (UK)
Condition
Schizophrenia
RecruitingISRCTN74919979

Information technology in mental health

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Finland.

SchizophreniaOtherOver 18 Years
Countries
Finland
Sponsor
Academy of Finland (Finland)
Condition
Schizophrenia
RecruitingISRCTN61794329

Does oral N-acetyl-cysteine (NAC) improve schizophrenia symptoms?

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Switzerland, United States of America.

SchizophreniaOther
Countries
Switzerland, United States of America
Sponsor
Swiss National Science Foundation (Fonds National Suisse de la Recherche Scientifique [SNSF]) (Switzerland)
Condition
Schizophrenia
RecruitingISRCTN56877013

A randomised trial comparing the clinical and cost effectiveness of usual, facility based care compared to an additional collaborative community care package for people and their families living with schizophrenia in India

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, India.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England, India
Sponsor
Kings College London (UK)
Condition
Schizophrenia
RecruitingISRCTN50247539

Reflex

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen (UMCG) (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN64695913

Safety and efficacy trial of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States of America.

SchizophreniaOtherOver 18 Years
Countries
Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States of America
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN44297014

A phase III randomised, double-blind, active comparator-controlled clinical trial to study the safety and efficacy of lurasidone in subjects with schizophrenia (PEARL 3 extension study)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States of America.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States of America
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN33909010

A phase 3 randomised placebo- and active comparator-controlled, clinical trial to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic patients with schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Bulgaria, Colombia, India, Lithuania, Peru, Philippines, Serbia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England, Bulgaria, Colombia, India, Lithuania, Peru, Philippines, Serbia
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN16838597

A phase three randomised, placebo-controlled, clinical trial to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic patients with schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, France, India, Malaysia, Romania, Russian Federation, Ukraine, United States of America.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England, France, India, Malaysia, Romania, Russian Federation, Ukraine, United States of America
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN97049967

Phase 3 long-term safety, tolerability and effectiveness of lurasidone in subjects with schizophrenia or schizoaffective disorder

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Argentina, Brazil, Chile, Croatia, Israel, South Africa, Thailand.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United Kingdom, England, Argentina, Brazil, Chile, Croatia, Israel, South Africa, Thailand
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
RecruitingISRCTN95205723

Metacognitive skill training for schizophrenic patients

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Germany.

SchizophreniaOther
Countries
Germany
Sponsor
German Research Foundation (DFG)/Federal Ministry of Education and Research (BMBF) (Germany)
Condition
Schizophrenia
RecruitingISRCTN11138647

Relapse Prevention Group Programme for service users with an international statistical classification of diseases and related health problems (ICD10, chapter F20) diagnosis of schizophrenia in a community setting - a randomised controlled trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United Kingdom, England
Sponsor
Brent Mental Health Service (UK)
Condition
Schizophrenia
RecruitingISRCTN06332944

Schizophrenia Termination Of Pharmacotherapy: STOP-trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN16228411

Medication strategies in first onset schizophrenia (Mesifos)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Netherlands
Sponsor
University Medical Centre Groningen (UMCG) (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN68736636

The European First Episode Schizophrenia Trial (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Israel, Italy, Netherlands, Poland, Romania, Spain, Sweden, Switzerland.

SchizophreniaOtherOver 18 Years
Countries
Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Israel, Italy, Netherlands, Poland, Romania, Spain, Sweden, Switzerland
Sponsor
European Group for Research in Schizophrenia (EGRIS) (Austria)
Condition
Schizophrenia
RecruitingISRCTN73679874

Brixton Early Psychosis Project

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia
RecruitingISRCTN78915298

Evaluation of a carers' support programme

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Condition
Schizophrenia
RecruitingISRCTN65818527

Study Of Cognitive ReAlignment Therapy in Early Schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom, England
Sponsor
Medical Research Council (MRC) (UK)
Condition
Schizophrenia
RecruitingISRCTN39471182

Narrative exposure therapy in early intervention in psychosis: a study providing an initial assessment of safety and acceptability of this psychological therapy for individuals with a first episode of psychosis who have experienced repeated trauma

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom, England
Sponsor
University College London
Condition
Schizophrenia
RecruitingISRCTN51908674

Understanding motivation problems in clinical disorders

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United Kingdom, England
Sponsor
University of Birmingham
Condition
Schizophrenia
RecruitingISRCTN71800376

Sleeping Better

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 14 Years
Countries
United Kingdom, England
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingISRCTN15897915

Talking With Voices II

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 16 Years to 110 Years
Countries
United Kingdom, England
Sponsor
Greater Manchester Mental Health NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN10250113

The Phoenix virtual reality self-confidence study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
United Kingdom, England
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingISRCTN14082421

Care coordinator delivered method of levels for psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Greater Manchester Mental Health NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN11913964

Psycho-social treatment for people with psychosis in south eastern Europe

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia, Serbia.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
Bosnia and Herzegovina, Kosovo, Montenegro, North Macedonia, Serbia
Sponsor
European Commission, Directorate-General for Research and Innovation
Condition
Schizophrenia
RecruitingISRCTN10334895

Cannabidiol for the treatment of patients at a high-risk of psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United Kingdom, England
Sponsor
King’s College London and South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN17776666

CARMS v1: Cognitive approaches to combatting suicidality

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
The University of Manchester
Condition
Schizophrenia
RecruitingISRCTN11177045

IVIG and rituximab in antibody-associated psychosis - SINAPPS2

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherFrom 16 Years to 70 Years
Countries
United Kingdom, England
Sponsor
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
Condition
Schizophrenia
RecruitingISRCTN80567433

Managing adolescent first episode psychosis: a feasibility study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Greater Manchester West Mental Health NHS Foundation Trust
Condition
Schizophrenia
RecruitingISRCTN49141214

The benefit of minocycline on negative symptoms in schizophrenia

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Scotland.

SchizophreniaOther
Countries
United Kingdom, England, Scotland
Sponsor
Manchester Mental Health And Social Care NHS Trust
Condition
Schizophrenia
RecruitingISRCTN13359355

Next Level: Method of Levels for Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
The University of Manchester
Condition
Schizophrenia
RecruitingISRCTN12668007

The nightmare intervention study

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
University of Oxford
Condition
Schizophrenia
RecruitingISRCTN37625384

Brief talking therapies on wards

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
King's College London
Condition
Schizophrenia
RecruitingISRCTN83240263

The MILESTONE study: improving transition from child to adult mental health care

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England, Belgium, Croatia, France, Germany, Ireland, Italy, Netherlands.

SchizophreniaOther
Countries
United Kingdom, England, Belgium, Croatia, France, Germany, Ireland, Italy, Netherlands
Sponsor
University of Warwick
Condition
Schizophrenia
RecruitingISRCTN47185233

Optimising team functioning, preventing relapse and enhancing recovery in Crisis Resolution Teams (CRTs): the CORE Programme (Crisis team Optimisation and RElapse prevention) CORE Phase 4: A Cluster Randomised Controlled Trial: Evaluation of implementation of a CRT Resource Kit

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Camden and Islington NHS Foundation Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN99672552

Focusing on clozapine unresponsive symptoms trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOther
Countries
United Kingdom, England
Sponsor
Greater Manchester West Mental Health NHS Foundation Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN33695128

Better Sleep Trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
University of Oxford (UK)
Condition
Schizophrenia
RecruitingISRCTN79584912

Treating trauma in psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
Stichting tot Steun VCVGZ (Netherlands)
Condition
Schizophrenia
RecruitingISRCTN02507940

REFOCUS Randomised Controlled Trial (RCT)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
King's College London (KCL)
Condition
Schizophrenia
RecruitingISRCTN16939126

Cognitive Behavioural Suicide Prevention for psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
University of Manchester (UK)
Condition
Schizophrenia
RecruitingISRCTN69299093

Relatives Education And Coping Toolkit (REACT)

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Lancashire Care NHS Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN73110773

Oxford Community Treatment Order Evaluation Trial

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust (UK)
Condition
Schizophrenia
RecruitingISRCTN21353122

The prevention of psychosis in at risk mental state

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Condition
Schizophrenia
RecruitingISRCTN83557988

Psychological Prevention of Relapse in Psychosis

This recruiting study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, England.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom, England
Sponsor
King's College London (UK)
Condition
Schizophrenia
OngoingEUCTR 2014-003008-53

Clonidine Augmentation Therapy in Schizophrenia

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOther
Countries
Netherlands
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
OngoingEUCTR 2020-006062-36

A PHASE II/III, PROSPECTIVE, MULTI-CENTER, RANDOMIZED, 4-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, DESIGNED TO DETERMINE THE SAFETY, TOLERABILITY, EEG EFFECTS AND EFFICACY OF ORAL DOSES OF 30 M...

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Germany, Italy, Czech Republic, Spain, Romania, Hungary, Poland, Estonia, Latvia, View results.

SchizophreniaOther
Countries
Germany, Italy, Czech Republic, Spain, Romania, Hungary, Poland, Estonia, Latvia, View results
Sponsor
Newron Pharmaceuticals S.p.A.
Condition
Schizophrenia
OngoingEUCTR 2017-001447-12

A Multicenter, Randomized, Double-blind, Placebo- and Active controlled Trial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 years old) With Schizophr...

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Hungary, Spain, Poland, Bulgaria, France, Italy, Romania, View results.

SchizophreniaOther
Countries
Hungary, Spain, Poland, Bulgaria, France, Italy, Romania, View results
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
OngoingEUCTR 2019-003343-29

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE 2)

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Czech Republic, Poland, Hungary, Bulgaria, Spain, Lithuania, Italy, Croatia, View results.

SchizophreniaOther
Countries
Czech Republic, Poland, Hungary, Bulgaria, Spain, Lithuania, Italy, Croatia, View results
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
OngoingEUCTR 2016-003435-38

A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Hungary, Spain, Bulgaria, Czech Republic, Germany, Lithuania, Poland, Italy, Croatia, View results.

SchizophreniaOther
Countries
Hungary, Spain, Bulgaria, Czech Republic, Germany, Lithuania, Poland, Italy, Croatia, View results
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
OngoingEUCTR 2020-003745-11

An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X)

This ongoing study focuses on schizophrenia and currently lists sites or participation links in France, Czech Republic, Spain, Slovakia, Hungary, Norway, Denmark, Lithuania, Italy, GR, Belgium, Sweden, Netherlands, Finland, Croatia, Austria, Bulgaria, Portugal, Romania.

SchizophreniaOther
Countries
France, Czech Republic, Spain, Slovakia, Hungary, Norway, Denmark, Lithuania, Italy, GR, Belgium, Sweden, Netherlands, Finland, Croatia, Austria, Bulgaria, Portugal, Romania
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
OngoingEUCTR 2019-003623-37

CANnabidiol for Parkinson’s Disease Psychosis

This ongoing study focuses on schizophrenia and currently lists sites or participation links in United Kingdom.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
OngoingEUCTR 2022-001515-10

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease Deme...

This ongoing study focuses on schizophrenia and currently lists sites or participation links in Spain, Slovakia, France, Italy, Bulgaria, Germany.

SchizophreniaOther
Countries
Spain, Slovakia, France, Italy, Bulgaria, Germany
Sponsor
Karuna Therapeutics
Condition
Schizophrenia
OngoingEUCTR 2017-002227-13

A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia-related Psychosis

This ongoing study focuses on schizophrenia and currently lists sites or participation links in United Kingdom, Czech Republic, Slovakia, Bulgaria, Spain, Poland, France, Italy, View results.

SchizophreniaOther
Countries
United Kingdom, Czech Republic, Slovakia, Bulgaria, Spain, Poland, France, Italy, View results
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
HopeStage Research Studies